Approval · Notice of Compliance 7815 · 2006
VASERETIC: Notice of Compliance 7815
Issued March 8, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7815
- Date
- March 8, 2006
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updating the indication for the treatment of essential hypertension in patients for whom this combination therapy is appropriate
- Therapeutic class
- Angiotensin converting enzyme inhibitor / diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VASERETIC | Not yet assigned | — |
Medicinal ingredients
- ENALAPRIL MALEATE 5 MG per TAB
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- ENALAPRIL MALEATE 10 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB